ArticleMolecules (Basel, Switzerland)2026
Effects of
Yeon-Yong Kim, Hyun-Jae Jang, Seungwon Jeong, Seung Woong Lee, Sang-Hyun Kim, Soyoung Lee
Abstract read
In one paragraphArticle in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Yeon-Yong KimFunctional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 181, Ipsin-gil, Jeongeup 56212, Republic of Korea.
Hyun-Jae JangFunctional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 181, Ipsin-gil, Jeongeup 56212, Republic of Korea.ORCID 0000-0002-4383-4465 Seungwon JeongDepartment of Bionanotechnology and Bioconvergence Engineering, Jeonbuk National University, 567, Baekje-daero, Jeonju 54896, Republic of Korea.
Seung Woong LeeFunctional Biomaterial Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 181, Ipsin-gil, Jeongeup 56212, Republic of Korea.ORCID 0000-0003-1025-7363 Sang-Hyun KimCell Matrix Research Institute, Department of Pharmacology, School of Medicine, Kyungpook National University, 680, Gukchaebosang-ro, Daegu 41944, Republic of Korea.
Soyoung LeeDepartment of Innovative Pharmaceutical Sciences, Advanced Institute of Science and Technology, Kyungpook National University, 80, Daehak-ro, Daegu 41566, Republic of Korea.
Funding
National Research Foundation of Korea RS-2022-NR067413National Research Foundation of Korea RS-2023-00301914National Research Foundation of Korea RS-2024-00338822National Research Foundation of Korea RS-2026-25504546
6 · The paper itselfAbstract
Asthma is a chronic allergic airway inflammation that requires ongoing therapeutic intervention and reduces the patient's quality of life. Therefore, safe and efficacious drugs for the treatment of asthma are urgently needed. This study investigated whether the ethyl acetate fraction derived from a 95% (
Indexed as
AsthmaMast CellsPlant ExtractsSignal TransductionAnimalsBronchoalveolar Lavage FluidCell DegranulationCytokinesDisease Models, AnimalFemaleImmunoglobulin ELungMiceMice, Inbred BALB CNF-kappa BOvalbuminCytokinesImmunoglobulin ENF-kappa BOvalbuminPhospholipase C gammaPlant ExtractsProto-Oncogene Proteins c-aktairway inflammationallergic asthmaAmpelopsis brevipedunculata (Maxim.) Trautv.degranulationmast cell
Identifiers
PMID42883244
PMCPMC13666435
What OpenQuestion holds
Textmetadata
Read underepoch 390